Display options
Cite
McIntosh M, Opozda MJ, Evans H, et al. A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. Psychooncology. 2019;28(12):2307-2322doi: 10.1002/pon.5262.
McIntosh, M., Opozda, M. J., Evans, H., Finlay, A., Galvão, D. A., Chambers, S. K., & Short, C. E. (2019). A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. Psycho-oncology, 28(12), 2307-2322. https://doi.org/10.1002/pon.5262
McIntosh, Megan, et al. "A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer." Psycho-oncology vol. 28,12 (2019): 2307-2322. doi: https://doi.org/10.1002/pon.5262
McIntosh M, Opozda MJ, Evans H, Finlay A, Galvão DA, Chambers SK, Short CE. A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. Psychooncology. 2019 Dec;28(12):2307-2322. doi: 10.1002/pon.5262. Epub 2019 Nov 06. PMID: 31663180.
Copy Download .nbib Format: NLM
Share it on

Psychooncology. 2019 Dec;28(12):2307-2322. doi: 10.1002/pon.5262. Epub 2019 Nov 06.

A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer.

Psycho-oncology

Megan McIntosh, Melissa J Opozda, Holly Evans, Amy Finlay, Daniel A Galvão, Suzanne K Chambers, Camille E Short

Affiliations

  1. Freemasons Foundation Centre for Men's Health, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
  2. Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  3. University of Technology Sydney, Sydney, New South Wales, Australia.
  4. University of Southern Queensland, Toowoomba, Queensland, Australia.
  5. Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia.
  6. Melbourne School of Psychological Sciences and Melbourne School of Health Sciences (jointly appointed), The University of Melbourne, Melbourne, VIC, Australia.

PMID: 31663180 DOI: 10.1002/pon.5262

Abstract

OBJECTIVE: Understanding the unmet supportive care needs of men on active surveillance for prostate cancer may enable researchers and health professionals to better support men and prevent discontinuation when there is no evidence of disease progression. This review aimed to identify the specific unmet supportive care needs of men on active surveillance.

METHODS: A systematic review following PRISMA guidelines was conducted. Databases (Pubmed, Embase, PsycINFO, and CINAHL) were searched to identify qualitative and/or quantitative studies that reported unmet needs specific to men on active surveillance. Quality appraisals were conducted before results were narratively synthesised.

RESULTS: Of the 3613 unique records identified, only eight articles were eligible (five qualitative and three cross-sectional studies). Unmet Informational, Emotional/Psychological, Social, and "Other" needs were identified. Only three studies had a primary aim of investigating unmet supportive care needs. Small active surveillance samples, use of nonvalidated measures, and minimal reporting of author reflexivity in qualitative studies were the main quality issues identified.

CONCLUSIONS: The unmet needs of men on active surveillance is an underresearched area. Preliminary evidence suggests the information available and provided to men during active surveillance is perceived as inadequate and inconsistent. Men may also be experiencing unmet psychological/emotional, social, and other needs; however, further representative, high-quality research is required to understand the magnitude of this issue. Reporting results specific to treatment type and utilising relevant theories/models (such as the social ecological model [SEM]) is recommended to ensure factors that may facilitate unmet needs are appropriately considered and reported.

© 2019 John Wiley & Sons, Ltd.

Keywords: active surveillance; prostate cancer; supportive care needs; systematic review

References

  1. Australian Institute of Health and Welfare (AIHW). Cancer in Australia: an overview. Vol. 90. Canberra; 2014. - PubMed
  2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-29. - PubMed
  3. Ruseckaite R, Beckmann K, Callaghan M, et al. A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease. BMC Cancer. 2016;16(1):607. - PubMed
  4. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117-1123. Available from: http://ascopubs.org/doi/10.1200/JCO.2009.26.0133 - PubMed
  5. Bellardita L, Valdagni R, van Den Bergh R, et al. How does active surveillance for prostate cancer affect quality of life? A systematic review. Eur Urol. 2015;67(4):637-645. Available from: https://www.europeanurology.com/article/S0302-2838(14)01101-4/pdf - PubMed
  6. Cancer Council Australia. Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines Expert Advisory Panel. Clinical practice guidelines PSA testing and early management of test-detected prostate cancer [Internet]. Cancer Council Australia; 2014. Available from: http://wiki.cancer.org.au/australia/Guidelines:PSA_Testing/Active_surveillance - PubMed
  7. Bokhorst LP, Valdagni R, Rannikko A, et al. A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment. Eur Urol. 2016;70(6):954-960. Available from:. https://www.europeanurology.com/article/S0302-2838(16)30277-9/pdf - PubMed
  8. Prostate Cancer: Clinically Localized Guideline - American Urological Association [Internet]. 2017 [cited 2019 Aug 22]. Available from: https://www.auanet.org/guidelines/prostate-cancer-clinically-localized-guideline - PubMed
  9. Carter G, Clover K, Britton B, et al. Wellbeing during Active Surveillance for localised prostate cancer: a systematic review of psychological morbidity and quality of life. Cancer Treat Rev. 2015;41(1):46-60. Available from: https://www.cancertreatmentreviews.com/article/S0305-7372(14)00176-5/fulltext - PubMed
  10. Hamdy FC, Donovan JL, Lane JA, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415-1424. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1606220 - PubMed
  11. Ruane-Mcateer E, Porter S, Sullivan JM, Santin O, Prue G. Active surveillance for favourable-risk prostate cancer: is there a greater psychological impact than previously thought? A systematic, mixed studies literature review. Psychooncology. 2017;26(10):1411-1421. - PubMed
  12. Egger SJ, Calopedos RJ, OConnell DL, Chambers SK, Woo HH, Smith DP. Long-term psychological and quality-of-life effects of active surveillance and watchful waiting after diagnosis of low-risk localised prostate cancer. Eur Urol. 2017;73(6):859-867. - PubMed
  13. Volk RJ, McFall SL, Cantor SB, et al. ‘It's not like you just had a heart attack’: decision-making about active surveillance by men with localized prostate cancer. Psychooncology. 2014;23(4):467-472. - PubMed
  14. Ervik B, Nordøy T, Asplund K. Hit by waves-living with local advanced or localized prostate cancer treated with endocrine therapy or under active surveillance. Cancer Nurs. 2010;33(5):382-389. - PubMed
  15. Hedestig O, Sandman P-O, Widmark A. Living with untreated localized prostate cancer: a qualitative analysis of patient narratives. Cancer Nurs. 2003;26(1):55-60. - PubMed
  16. Berger Z, Yeh J, Carter H, Pollack C. Characteristics and Experiences of patients with localized prostate cancer who left an active surveillance program. Patient. 2014;7(4):427-436. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332784/pdf/nihms659349.pdf - PubMed
  17. Kinsella N, Stattin P, Cahill D, et al. Factors influencing men's choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review. Eur Urol. 2018;74(3):261-280. Available from: https://www.europeanurology.com/article/S0302-2838(18)30176-3/pdf - PubMed
  18. Van Hemelrijck M, Ji X, Helleman J, et al. Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the movember GAP3 consortium. Eur Urol. 2018;75(3):523-531. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30385049 - PubMed
  19. Kinsella N, Helleman J, Bruinsma S, et al. Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices. Transl Androl Urol. 2018;7(1):83-97. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861285/pdf/tau-07-01-83.pdf - PubMed
  20. Simpkin AJ, Tilling K, Martin RM, et al. Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer. Eur Urol. 2015;67(6):993-1005. - PubMed
  21. Fitch MI. Supportive care framework. Can Oncol Nurs J. 2008;18(1):6. Available from:http://canadianoncologynursingjournal.com/index.php/conj/article/download/248/251-24. - PubMed
  22. Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer. 2009;17(8):1117-1128. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19319577 - PubMed
  23. Institute of Medicine. Cancer care for the whole partient: meeting psychosocial health needs. Adler NE, Page AEK, editors. Washington, DC: The National Academies Press; 2008. - PubMed
  24. Newell S, Sanson-Fisher RW, Girgis A, Ackland S. The physical and psycho-social experiences of patients attending an outpatient medical oncology department: a cross-sectional study. Eur J Cancer Care (Engl). 1999;8(2):73-82. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2354.1999.00125.x. - PubMed
  25. Boyes A, Girgis A, Lecathelinais C. Brief assessment of adult cancer patients perceived needs: development and validation of the 34-item Supportive Care Needs Survey SCNS-SF34. J Eval Clin Pract. 2009;15(4):602-606. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2753.2008.01057.x - PubMed
  26. Paterson C, Robertson A, Smith A, Nabi G. Identifying the unmet supportive care needs of men living with and beyond prostate cancer: a systematic review. Eur J Oncol Nurs. 2015;19(4):405-418. - PubMed
  27. King AJL, Evans M, Moore THM, et al. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. Eur J Cancer Care (Engl). 2015;24:618-634. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024073/pdf/ECC-24-618.pdf - PubMed
  28. Steginga SK, Occhipinti S, Dunn J, Gardiner RA, Heathcote P, Yaxley J. The supportive care needs of men with prostate cancer. Psychooncology. 2001;10(1):66-75. - PubMed
  29. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19621072 - PubMed
  30. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147-153. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26317388 - PubMed
  31. Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc. 2015;13(3):179-187. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26262565 - PubMed
  32. Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18616818 - PubMed
  33. Loeb S, Curnyn C, Fagerlin A, et al. Informational needs during active surveillance for prostate cancer: a qualitative study. Patient Educ Couns. 2018;100(9):241-247. N.PAG-N.PAG. Available from: http://proxy.library.adelaide.edu.au/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=c8h&AN=125190673&site=ehost-live&scope=site - PubMed
  34. Kazer MW, Bailey DE, Colberg J, Kelly WK, Carroll P. The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs. 2011;20(3-4):581-586. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L361078342 - PubMed
  35. Avery KN, Donovan JL, Horwood J, et al. The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals. BMC Fam Pract. 2014;15:81. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L603802359 - PubMed
  36. Mróz LW, Oliffe JL, Davison JB. Masculinities and patient perspectives of communication about active surveillance for prostate cancer. Kazak AE, Gough B, editors. Health Psychol. 2013;32(1):83-90. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L369492234 - PubMed
  37. O'Callaghan C, Dryden T, Hyatt A, et al. “What is this active surveillance thing?” Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option. Psychooncology. 2014;23(12):1391-1398. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L53139578 - PubMed
  38. Bergengren O, Garmo H, Bratt O, Holmberg L, Johansson E, Bill-Axelson A. Satisfaction with care among men with localised prostate cancer: a nationwide population-based study. Eur Urol Oncol. 2018;1(1):37-45. Available from: https://ac.els-cdn.com/S2588931118300087/1-s2.0-S2588931118300087-main.pdf?_tid=b3243286-4116-4f1a-913c-a9da623ab959&acdnat=1544054185_50c307bc85011c40b2f47882515a7156 - PubMed
  39. Boberg EW, Gustafson DH, Hawkins RP, et al. Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns. 2003;49(3):233-242. - PubMed
  40. Davison BJ, Goldenberg SL. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int. 2011;108(11):1787-1793. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L51381790 - PubMed
  41. Tracy SJ. Qualitative Quality: Eight “Big-Tent” Criteria for Excellent Qualitative Research. Qual Inq. 2010;16(10):837-851. - PubMed
  42. Bronfenbrenner U. The ecology of human development: experiments by nature and design [Internet]. Harvard University Press; 1979 [cited 2019 Mar 5]. 330 p. Available from: https://books.google.com.au/books?hl=en&lr=&id=OCmbzWka6xUC&oi=fnd&pg=PA3&dq=bronfenbrenner+&ots=yyOWQ0YTkf&sig=NWnC4ZrV66dDH_8xnpJIb7M2_9o#v=onepage&q=bronfenbrenner&f=false - PubMed
  43. Beesley V, Eakin E, Steginga S, Aitken J, Dunn J, Battistutta D. Unmet needs of gynaecological cancer survivors: implications for developing community support services. Psychooncology. 2008;17(4):392-400. Available from: http://doi.wiley.com/10.1002/pon.1249 - PubMed
  44. Mitchell J. Examining the influence of social ecological factors on prostate cancer screening in urban African-American men. Soc Work Health Care. 2011;50(8):639-655. Available from: http://www.tandfonline.com/doi/abs/10.1080/00981389.2011.589891 - PubMed
  45. Woods VD, Montgomery SB, Herring RP, Gardner RW, Stokols D. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men. J Natl Med Assoc. 2006;98(4):492. Available from:-504. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569227/ - PubMed
  46. Matheson L, Wilding S, Wagland R, et al. The psychological impact of being on a monitoring pathway for localised prostate cancer: a UK-wide mixed methods study. Psychooncology. 2019;28(7):pon.5133. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.5133 - PubMed
  47. Short CE, Gelder C, Binnewerg L, McIntosh M, Turnbull D. Examining the accessibility of high quality physical activity behaviour change support freely available online for men with prostate cancer. J Cancer Surviv. 2017;12(1):10-17. - PubMed
  48. Cher ML, Dhir A, Auffenberg GB, et al. Appropriateness criteria for active surveillance of prostate cancer. J Urol. 2017;197(1):67-74. Available from: http://www.jurology.com/doi/10.1016/j.juro.2016.07.005 - PubMed
  49. Ruane-McAteer E, Porter S, O'Sullivan J, Dempster M, Prue G. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: a 9-month longitudinal study. Psychooncology. 2019;28(8):pon.5161. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.5161 - PubMed
  50. Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012;87(3):369-374. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0738399111005726 - PubMed
  51. Chipperfield K, Fletcher J, Millar J, et al. Factors associated with adherence to physical activity guidelines in patients with prostate cancer. Psychooncology. 2013;22(11):2478. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.3310 - PubMed
  52. Galvão DA, Dennis RT, Nigel S, et al. Enhancing active surveillance of prostate cancer: the potential of exercise medicine. Nat Rev Urol. 2016;12(5):258-265. Available from:. https://www.nature.com/articles/nrurol.2016.46 - PubMed
  53. Galvão DA, Newton RU, Gardiner RA, et al. Compliance to exercise-oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life. Psychooncology. 2015;24(10):1241-1249. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/pon.3882 - PubMed
  54. Cormie P, Oliffe JL, Wootten AC, et al. Improving psychosocial health in men with prostate cancer through an intervention that reinforces masculine values-exercise. Psychooncology. 2015;25(2):232-235. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.3867 - PubMed
  55. McIntosh M, Opozda M, Galvão DA, Chambers SK, Short CE. Identifying the exercise-based support needs and exercise programme preferences among men with prostate cancer during active surveillance: a qualitative study. Eur J Oncol Nurs. 2019;41:135-142. Available from: https://www.sciencedirect.com/science/article/pii/S1462388919300742?dgcid=author - PubMed
  56. Galvão DA, Newton RU, Girgis A, et al. Randomized controlled trial of a peer led multimodal intervention for men with prostate cancer to increase exercise participation. Psychooncology. 2018;27(1):199-207. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28685892 - PubMed
  57. O'Brien R, Rose P, Campbell C, et al. “I wish I'd told them”: a qualitative study examining the unmet psychosexual needs of prostate cancer patients during follow- up after treatment. Patient Educ Couns. 2011;84(2):200-207. - PubMed
  58. McDowell ME, Occhipinti S, Ferguson M, Dunn J, Chambers SK. Predictors of change in unmet supportive care needs in cancer. Psychooncology. 2010;19(5):508-516. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19598292 - PubMed
  59. Armes J, Crowe M, Colbourne L, et al. Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27(36):6172-6179. Available from: http://ascopubs.org/doi/10.1200/JCO.2009.22.5151 - PubMed
  60. Spellman C, Craike M, Livingston PM. Knowledge, attitudes and practices of clinicians in promoting physical activity to prostate cancer survivors. Health Educ J. 2014;73(5):566-575. - PubMed
  61. Barnes K, Ball L, Galvão DA, Newton RU, Chambers SK, Harrison C. Physical activity counselling and referrals by general practitioners for prostate cancer survivors in Australia. Aust J Prim Health. 2019;25(2):152-156. Available from: http://www.publish.csiro.au/?paper=PY18131 - PubMed
  62. Macefield RC, Metcalfe C, Lane JA, et al. Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Cancer. 2010;102(9):1335-1340. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20372151 - PubMed
  63. Evans SM, Nag N, Roder D, et al. Development of an international prostate cancer outcomes registry. BJU Int. 2016;117:60-67. Available from: www.bjui.org - PubMed

MeSH terms

Publication Types